TGRNF (Tong Ren Tang Technologies Co) Other Stockholders Equity: $227.4 Mil (As of Dec. 2025)


TGRNF Tong Ren Tang Technologies Co Ltd TGRNF
50 GF Score
Price $0.49
GF Value $0.84
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Tong Ren Tang Technologies Co Other Stockholders Equity?

Tong Ren Tang Technologies Co TGRNF 50 Other Stockholders Equity is $227.4 Mil as of Dec. 2025. GuruFocus rates TGRNF with a GF Score™ of 50/100 and a GF Value™ of $0.84 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Tong Ren Tang Technologies Co's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $227.4 Mil.

Tong Ren Tang Technologies Co's quarterly Other Stockholders Equity increased from Dec. 2024 ($219.0 Mil) to Jun. 2025 ($219.5 Mil) and increased from Jun. 2025 ($219.5 Mil) to Dec. 2025 ($227.4 Mil).

Tong Ren Tang Technologies Co's annual Other Stockholders Equity increased from Dec. 2023 ($215.3 Mil) to Dec. 2024 ($219.0 Mil) and increased from Dec. 2024 ($219.0 Mil) to Dec. 2025 ($227.4 Mil).

Tong Ren Tang Technologies Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Tong Ren Tang Technologies Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tong Ren Tang Technologies Co Other Stockholders Equity Chart

Tong Ren Tang Technologies Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 201.84 210.05 215.34 218.95 227.36

Tong Ren Tang Technologies Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215.34 213.05 218.95 219.48 227.36
TGRNF
50GF Score
Tong Ren Tang Technologies Co Ltd TGRNF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tong Ren Tang Technologies Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $227.4 Mil mean?
Tong Ren Tang Technologies Co (TGRNF) has a Other Stockholders Equity of $227.4 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Tong Ren Tang Technologies Co and its competitors.
Is Tong Ren Tang Technologies Co's Other Stockholders Equity too high?
Tong Ren Tang Technologies Co's current Other Stockholders Equity is $227.4 Mil. Overall, Tong Ren Tang Technologies Co has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tong Ren Tang Technologies Co's Other Stockholders Equity compare to LLY and JNJ?
Tong Ren Tang Technologies Co's Other Stockholders Equity of $227.4 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Tong Ren Tang Technologies Co and its competitors. Tong Ren Tang Technologies Co's current Other Stockholders Equity is $227.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tong Ren Tang Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co (TGRNF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.84, compared to a current price of $0.49 — trading 41.1% below its estimated fair value. The current Other Stockholders Equity is $227.4 Mil. Tong Ren Tang Technologies Co's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Tong Ren Tang Technologies Co (TGRNF), the current Other Stockholders Equity is $227.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tong Ren Tang Technologies Co (TGRNF) Overvalued in 2026?

Based on GuruFocus' analysis, Tong Ren Tang Technologies Co stock appears to be undervalued. The current stock price of $0.49 is trading 41.1% below its estimated GF Value™ of $0.84. GuruFocus considers Tong Ren Tang Technologies Co to be Significantly Undervalued.

Key valuation signals for TGRNF:

  • Other Stockholders Equity: $227.4 Mil
  • GF Value™: $0.84 vs. price of $0.49 (41.1% below fair value)
  • GF Score™: 50/100 with 5 warning signs

No single metric tells the full story. See the TGRNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tong Ren Tang Technologies Co Business Description

Other Exchanges 01666:Hong KongTNG:Germany
Address No. 16 Tongji Beilu, Beijing Economic and Technological Development Zone, Beijing, CHN
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
50GF Score

Get the complete analysis for TGRNF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.49
Price
$0.84
GF Value